EchoIQ Limited provides cardiac diagnostics technology solution in Australia. The company's artificial intelligence-assisted diagnostics technology supports the sensitive diagnosis of Aortic Stenosis. It primarily serves device manufacturers, cardio scanning equipment, pharmaceuticals, and healthcare providers and insurers, as well as clinicians and patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. EchoIQ Limited is based in St Leonards, Australia.
Research context
Houston We Have Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Software
- Industry
- Information Technology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Houston We Have Limited is currently in a long term uptrend where the price is trading 86.8% above its 200 day moving average.
From a valuation standpoint, the stock is 78.4% cheaper than other stocks from the Technology sector with a price to sales ratio of 15.4.
Houston We Have Limited's total revenue rose by 139.5% to $502K since the same quarter in the previous year.
Its net income has increased by 42.5% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 38.4% to $-346K since the same quarter in the previous year.
Based on the above factors, Houston We Have Limited gets an overall score of 5/5.